Volume 44, Issue 6, Pages (June 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 60, Issue 1, Pages (January 2014)
Volume 66, Issue 4, Pages (April 2017)
Volume 62, Issue 6, Pages (June 2015)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 41, Issue 6, Pages (December 2004)
Inflammasomes in liver diseases
Volume 38, Issue 1, Pages (January 2006)
Volume 50, Issue 4, Pages (April 2009)
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 51, Issue 3, Pages (September 2009)
Primary prevention of variceal haemorrhage: A pharmacological approach
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 53, Issue 5, Pages (November 2010)
Volume 44, Issue 2, Pages (February 2006)
Immigration and viral hepatitis
Volume 67, Issue 2, Pages (August 2017)
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Quiz Page December 2007 American Journal of Kidney Diseases
Volume 42, Issue 2, Pages (February 2005)
Volume 42, Issue 4, Pages (April 2005)
The role of Epstein–Barr virus in acute and chronic hepatitis
Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease  Valerio Nobili, Naim Alkhouri,
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Maya Srivastava, Antonio Perez–Atayde, Maureen M. Jonas 
Volume 44, Issue 5, Pages (May 2006)
Volume 53, Issue 5, Pages (November 2010)
Hepatitis C core protein – The “core” of immune deception?
Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis  Zobair M. Younossi  Clinical.
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Michael Charlton  Clinical Gastroenterology and Hepatology 
Volume 53, Issue 5, Pages (November 2010)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 50, Issue 4, Pages (April 2009)
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 56, Issue 6, Pages (June 2012)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Volume 60, Issue 1, Pages (January 2014)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Volume 44, Issue 1, Pages (January 2006)
The relationship between age and fat infiltration in liver and muscle
Volume 53, Issue 1, Pages (July 2010)
Quiz Page January 2010 American Journal of Kidney Diseases
LSM = liver stiffness measure, CAP = controlled attenuation parameter.
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 64, Issue 6, Pages (June 2016)
Presentation transcript:

Volume 44, Issue 6, Pages 1167-1174 (June 2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2  John Willy Haukeland, Jan Kristian Damås, Zbigniew Konopski, Else Marit Løberg, Terese Haaland, Ingeborg Goverud, Peter A Torjesen, Kåre Birkeland, Kristian Bjøro, Pål Aukrust  Journal of Hepatology  Volume 44, Issue 6, Pages 1167-1174 (June 2006) DOI: 10.1016/j.jhep.2006.02.011 Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Box plots showing interquartile range (box), median (thick line), range (thin lines) and outliers (circles) for A serum TNF-α, B serum CCL2/MCP-1 and C serum adiponectin in healthy controls, in patients with simple steatosis and in patients with NASH. *P<0.05 and **P<0.001 vs controls. #P<0.05 vs simple steatosis. Journal of Hepatology 2006 44, 1167-1174DOI: (10.1016/j.jhep.2006.02.011) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Immunohistochemical staining for CCL2/MCP-1 in liver tissue from two patients with NASH. Original magnification ×160. (A) Portal inflammation with positive staining (dense brownish) in bile duct epithelium (upper arrowhead), endothelium (lower arrowhead) and leukocytes (arrows). (B) Centrilobular area with severe steatosis, positive staining is observed in leukocytes accumulating around a fat vacuole (arrow). Journal of Hepatology 2006 44, 1167-1174DOI: (10.1016/j.jhep.2006.02.011) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions